Brady’s first quarter saw double-digit sales growth, but results came in below Wall Street’s revenue expectations, leading to a significant negative market reaction. Management attributed the performance to strong organic growth in the Americas and Asia, especially in high-demand industrial identification products, while Europe and Australia lagged due to a weaker industrial environment. CEO Russell Schaller highlighted ongoing restructuring in underperforming regions and an uptick in R&D spending, saying, “We are in the position to drive future earnings growth in Europe due to the efficiency actions we’ve taken.”
Is now the time to buy BRC? Find out in our full research report (it’s free).
Brady (BRC) Q1 CY2025 Highlights:
- Revenue: $382.6 million vs analyst estimates of $386.6 million (11.4% year-on-year growth, 1% miss)
- Adjusted EPS: $1.22 vs analyst estimates of $1.22 (in line)
- Adjusted EBITDA: $86.76 million vs analyst estimates of $82 million (22.7% margin, 5.8% beat)
- Management reiterated its full-year Adjusted EPS guidance of $4.56 at the midpoint
- Operating Margin: 17.6%, in line with the same quarter last year
- Market Capitalization: $3.27 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our Top 5 Analyst Questions Brady’s Q1 Earnings Call
- Keith Housum (Northcoast Research) asked about the potential for tariffs to hurt demand or alter manufacturing locations; CEO Russell Schaller said no demand destruction is evident yet, but effects could emerge as inventory cycles through and price increases are implemented.
- Housum (Northcoast Research) questioned the sustainability of lower SG&A expenses; Schaller emphasized ongoing efforts to drive operational efficiency, though short-term fluctuations are possible, with a long-term goal of continued cost reduction.
- Housum (Northcoast Research) inquired about the strategic opportunity behind the Funai acquisition; Schaller detailed its potential to fill gaps in Brady’s direct part marking capabilities and provide a more complete industrial identification solution.
- Steve Ferazani (Sidoti) asked why guidance for Americas and Asia growth was conservative for next quarter despite recent strength; Schaller cited anticipated tariff headwinds in the U.S. and hopes for stabilization, not further decline, in Europe.
- Ferazani (Sidoti) requested detail on China trends; Schaller said China remains difficult but is less significant to overall results, with revenue largely tied to multinational customers and a recent facility closure to right-size operations.
Catalysts in Upcoming Quarters
In the coming quarters, the StockStory team will be watching (1) how well Brady can offset tariff-related cost increases through pricing or supply chain changes, (2) the pace of recovery or further decline in European industrial end markets, and (3) the commercial impact of new product launches and integration of recent acquisitions. Execution on R&D initiatives and continued operational discipline will also be key markers of progress.
Brady currently trades at $69.02, down from $76.22 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
Our Favorite Stocks Right Now
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.